Roeland Johannes Middelbeek, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obesity, Morbid | 3 | 2016 | 1277 | 0.680 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2022 | 3441 | 0.670 |
Why?
|
Glucuronidase | 1 | 2021 | 202 | 0.660 |
Why?
|
Prediabetic State | 2 | 2022 | 549 | 0.580 |
Why?
|
Bariatric Surgery | 3 | 2017 | 992 | 0.570 |
Why?
|
Exercise | 9 | 2023 | 5884 | 0.510 |
Why?
|
Physical Conditioning, Animal | 6 | 2021 | 365 | 0.500 |
Why?
|
European Union | 1 | 2015 | 157 | 0.470 |
Why?
|
Taxes | 1 | 2016 | 221 | 0.450 |
Why?
|
Adipose Tissue, White | 4 | 2023 | 365 | 0.450 |
Why?
|
Endocrine System Diseases | 1 | 2015 | 249 | 0.420 |
Why?
|
Glucose | 6 | 2021 | 4347 | 0.420 |
Why?
|
Endocrine Disruptors | 1 | 2015 | 264 | 0.390 |
Why?
|
Blood Glucose | 6 | 2022 | 6391 | 0.380 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5840 | 0.360 |
Why?
|
Sexually Transmitted Diseases | 1 | 2016 | 662 | 0.350 |
Why?
|
Weight Loss | 4 | 2021 | 2683 | 0.340 |
Why?
|
Adipose Tissue, Brown | 4 | 2023 | 764 | 0.300 |
Why?
|
Metabolome | 1 | 2014 | 987 | 0.290 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 12143 | 0.270 |
Why?
|
Gastric Bypass | 1 | 2014 | 818 | 0.260 |
Why?
|
Cytokines | 1 | 2021 | 7392 | 0.260 |
Why?
|
Telemedicine | 1 | 2023 | 3051 | 0.260 |
Why?
|
Hypoglycemic Agents | 3 | 2022 | 3081 | 0.250 |
Why?
|
Cost of Illness | 1 | 2015 | 1936 | 0.250 |
Why?
|
Insulin | 4 | 2022 | 6602 | 0.250 |
Why?
|
Pandemics | 2 | 2022 | 8641 | 0.230 |
Why?
|
Adaptation, Physiological | 3 | 2023 | 1301 | 0.220 |
Why?
|
Metformin | 1 | 2021 | 906 | 0.220 |
Why?
|
Lipids | 1 | 2014 | 3340 | 0.220 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1274 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3082 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3202 | 0.200 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 467 | 0.200 |
Why?
|
Environmental Exposure | 1 | 2015 | 4467 | 0.170 |
Why?
|
Motor Activity | 2 | 2023 | 2711 | 0.170 |
Why?
|
Hepatocyte Growth Factor | 1 | 2021 | 270 | 0.160 |
Why?
|
Adipokines | 2 | 2019 | 310 | 0.160 |
Why?
|
Quality of Life | 2 | 2021 | 13361 | 0.160 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 71 | 0.160 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 594 | 0.150 |
Why?
|
Chemokine CCL2 | 1 | 2021 | 605 | 0.150 |
Why?
|
Ecosystem | 1 | 2022 | 490 | 0.150 |
Why?
|
Oleic Acids | 1 | 2018 | 74 | 0.150 |
Why?
|
Adipose Tissue | 3 | 2023 | 3312 | 0.130 |
Why?
|
Maryland | 1 | 2016 | 277 | 0.130 |
Why?
|
Muscle, Skeletal | 5 | 2022 | 4946 | 0.120 |
Why?
|
Hypoglycemia | 1 | 2022 | 884 | 0.120 |
Why?
|
Mental Disorders | 1 | 2015 | 6841 | 0.120 |
Why?
|
Cardiovascular Diseases | 3 | 2021 | 15498 | 0.120 |
Why?
|
Energy Metabolism | 2 | 2017 | 2881 | 0.110 |
Why?
|
Interleukin-6 | 2 | 2021 | 3207 | 0.100 |
Why?
|
Leptin | 1 | 2021 | 1597 | 0.100 |
Why?
|
Humans | 25 | 2023 | 761423 | 0.100 |
Why?
|
Mesenchymal Stem Cells | 1 | 2022 | 1642 | 0.100 |
Why?
|
Placenta | 1 | 2021 | 1708 | 0.100 |
Why?
|
Subcutaneous Fat | 1 | 2015 | 393 | 0.100 |
Why?
|
Body Composition | 1 | 2021 | 2422 | 0.090 |
Why?
|
Fatty Acids | 1 | 2019 | 1808 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2374 | 0.090 |
Why?
|
Ethanol | 1 | 2016 | 1324 | 0.080 |
Why?
|
Life Style | 3 | 2021 | 3914 | 0.080 |
Why?
|
Adult | 10 | 2023 | 221148 | 0.080 |
Why?
|
Male | 15 | 2023 | 360736 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2023 | 22163 | 0.070 |
Why?
|
Hemoglobin A | 1 | 2007 | 84 | 0.070 |
Why?
|
Oxygen | 1 | 2018 | 4228 | 0.070 |
Why?
|
Oxygen Consumption | 3 | 2018 | 1863 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2010 | 1201 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5335 | 0.060 |
Why?
|
Postprandial Period | 1 | 2007 | 315 | 0.060 |
Why?
|
Mice | 10 | 2023 | 81509 | 0.060 |
Why?
|
Female | 11 | 2023 | 392581 | 0.060 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2021 | 598 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2017 | 3963 | 0.050 |
Why?
|
Obesity | 3 | 2023 | 12938 | 0.050 |
Why?
|
Acclimatization | 1 | 2023 | 113 | 0.050 |
Why?
|
Homeostasis | 1 | 2012 | 3321 | 0.050 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2023 | 263 | 0.050 |
Why?
|
Inguinal Canal | 1 | 2021 | 71 | 0.050 |
Why?
|
Insulin Infusion Systems | 1 | 2022 | 217 | 0.050 |
Why?
|
Fasting | 1 | 2007 | 1602 | 0.040 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2021 | 91 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2007 | 1793 | 0.040 |
Why?
|
Cell Transdifferentiation | 1 | 2021 | 185 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 2021 | 266 | 0.040 |
Why?
|
Animals | 10 | 2023 | 168441 | 0.040 |
Why?
|
Middle Aged | 5 | 2023 | 220826 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2021 | 360 | 0.040 |
Why?
|
Gastrointestinal Hormones | 1 | 2017 | 101 | 0.040 |
Why?
|
Body Mass Index | 1 | 2014 | 12951 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2076 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2021 | 14409 | 0.030 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 393 | 0.030 |
Why?
|
Cohort Studies | 2 | 2018 | 41446 | 0.030 |
Why?
|
Appetite | 1 | 2017 | 247 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 18964 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 2017 | 393 | 0.030 |
Why?
|
Vagus Nerve | 1 | 2017 | 458 | 0.030 |
Why?
|
Cold Temperature | 1 | 2018 | 786 | 0.030 |
Why?
|
Health | 1 | 2017 | 398 | 0.030 |
Why?
|
Hepatocytes | 1 | 2021 | 1232 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2022 | 2319 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2015 | 704 | 0.020 |
Why?
|
Sorbitol | 1 | 2010 | 57 | 0.020 |
Why?
|
Cell Line | 2 | 2018 | 15605 | 0.020 |
Why?
|
Reward | 1 | 2017 | 971 | 0.020 |
Why?
|
Ion Channels | 1 | 2015 | 1040 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2637 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2413 | 0.020 |
Why?
|
Transcription Factors | 2 | 2023 | 12125 | 0.020 |
Why?
|
Energy Intake | 1 | 2017 | 2134 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1902 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 976 | 0.020 |
Why?
|
Myoblasts | 1 | 2010 | 231 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3724 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4510 | 0.020 |
Why?
|
Intestines | 1 | 2017 | 1909 | 0.020 |
Why?
|
Adipocytes | 1 | 2015 | 1194 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 615 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 59207 | 0.020 |
Why?
|
Risk Factors | 2 | 2022 | 74167 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 88313 | 0.020 |
Why?
|
Biological Transport | 1 | 2010 | 2092 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7532 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2017 | 3187 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2010 | 3597 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2012 | 4808 | 0.010 |
Why?
|
Homocysteine | 1 | 2006 | 638 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5036 | 0.010 |
Why?
|
Mitochondria | 1 | 2015 | 3623 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2831 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8000 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15717 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8320 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29862 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2006 | 1723 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23441 | 0.010 |
Why?
|
Cholesterol | 1 | 2006 | 2902 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2006 | 2382 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58956 | 0.010 |
Why?
|
Smoking | 1 | 2006 | 9052 | 0.010 |
Why?
|
Aged | 1 | 2018 | 169235 | 0.000 |
Why?
|